APA (7th ed.) Citation

CY, H., CY, L., KW, L., YK, C., LY, L., YL, H., . . . CL, H. (2026). SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma. American journal of cancer research, 16(2), 496. https://doi.org/10.62347/OLMD6993

Chicago Style (17th ed.) Citation

CY, Huang, et al. "SSTR2-targeting Therapy in EBV-positive and EBV-negative Metastatic Nasopharyngeal Carcinoma." American Journal of Cancer Research 16, no. 2 (2026): 496. https://doi.org/10.62347/OLMD6993.

MLA (9th ed.) Citation

CY, Huang, et al. "SSTR2-targeting Therapy in EBV-positive and EBV-negative Metastatic Nasopharyngeal Carcinoma." American Journal of Cancer Research, vol. 16, no. 2, 2026, p. 496, https://doi.org/10.62347/OLMD6993.